Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
Titel:
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
Auteur:
Cho, Leslie Nicholls, Stephen J. Nordestgaard, Børge G. Landmesser, Ulf Tsimikas, Sotirios Blaha, Michael J. Leitersdorf, Eran Lincoff, A. Michael Lesogor, Anastasia Manning, Brian Kozlovski, Plamen Cao, Hui Wang, Jing Nissen, Steven E.